During the past decade, Parexel International GmbH conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Parexel International GmbH" #1 sponsor was "Astellas Pharma Europe B.V." with 7 trials, followed by "Orion Corporation, Orion Pharma" with 6 trials sponsored, "CellMed AG, a subsidiary of BTG plc." with 3 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 3 trials sponsored and "Samsung Bioepis Co., Ltd." with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Parexel International GmbH" #1 collaborator was "FibroGen" with 2 trials as a collaborator, "Medivation, Inc." with 2 trials as a collaborator and "Parexel" with 2 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Parexel International GmbH" are "Healthy" (11 trials), "Healthy Subjects" (9 trials), "Drug-Drug Interaction (DDI)" (3 trials), "Pharmacokinetics" (3 trials) and "Asthma" (2 trials). Many other conditions were trialed in "Parexel International GmbH" in a lesser frequency.

Most popular intervention types in "Parexel International GmbH" are "Drug" (26 trials), "Biological" (3 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "CM3.1-AC100" (3 trials), "Budesonide/formoterol Easyhaler" (2 trials), "Entacapone" (2 trials) and "FG-4592" (2 trials). Other intervention names were less common.

The vast majority of trials in "Parexel International GmbH" are 17 trials for "All" genders, 11 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Parexel International GmbH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Parexel International GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Parexel International GmbH, 25 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".